The chapter explores the unexpected consequences and far-reaching effects of weight-loss pills on industries such as airlines, Walmart, and apparel makers. It also discusses the significant discoveries in peptides and gut hormones made by scientists from the 70s and 80s, and speculates about future developments from Pfizer.
Bloomberg News Health Reporter Madison Muller explains how Pfizer’s second weight-loss setback this year is a warning sign that breaking into the lucrative obesity market isn’t going to be easy. Cory Klippsten, CEO at Swan Bitcoin, shares his crypto outlook for 2024. Benjamin Wolkon, Founding Partner at MUUS Climate Partners, talks about investing in climate funding. Bloomberg News Mexico Business Reporter Amy Stillman provides the details of her Businessweek Magazine story Chinese Sales Swamp Competition in Soaring Mexican Car Market. And we Drive to the Close with Carol Schleif, CIO at BMO Family Office.
Hosts: Carol Massar and Bailey Lipschultz. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.